Skip to main navigation Skip to search Skip to main content

Single dose of doxycycline for the prevention of tick-borne relapsing fever

  • Yoav Binenbaum
  • , Ronen Ben-Ami
  • , Gad Baneth
  • , Boaz Langford
  • , Yoav Negev
  • , Edwa Friedlander
  • , David Shasha
  • , Luba Tau
  • , Yael Paran

Research output: Contribution to journal › Article › peer-review

Abstract

The current postexposure prophylaxis regimen for tick-borne relapsing fever (TBRF) consists of 5 days' doxycycline. In this observational study of 77 spelunkers at high risk for TBRF, a single dose of 100 mg doxycycline taken up to 72 hours after exposure to ticks was 100% effective in p reventing the disease.

Original languageEnglish
Pages (from-to)1768-1771
Number of pages4
JournalClinical Infectious Diseases
Volume71
Issue number7
DOIs
StatePublished - 1 Oct 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Single dose of doxycycline for the prevention of tick-borne relapsing fever'. Together they form a unique fingerprint.

Cite this